tell me managment of accute COPD exacerbation according to NICE with doses
- User
tell me managment of accute COPD exacerbation according to NICE with doses
Assistant
Certainly! The management of acute exacerbations of Chronic Obstructive Pulmonary Disease (COPD) according to the National Institute for Health and Care Excellence (NICE) guidelines involves a combination of pharmacological and non-pharmacological interventions. Below is a summary of the key recommendations, including doses where applicable.
Initial Assessment and Oxygen Therapy
-
Assess Severity:
- Use clinical judgement to assess the severity of the exacerbation.
- Measure oxygen saturation using pulse oximetry.
-
Oxygen Therapy:
-
Target Oxygen Saturation: Aim for 88–92% in patients at risk of hypercapnic respiratory failure (known COPD with previous hypercapnia or those with a raised PaCO2 on arterial blood gas).
- Starting Dose: Begin with 24% or 28% venturi mask at 2–4 L/min.
- Adjust: Titrate oxygen to maintain target saturation.
-
Not at Risk of Hypercapnia: Target saturation 94–98%.
- Starting Dose: Use a 35% or 40% venturi mask at 4–10 L/min or nasal cannulae at 2–6 L/min.
- Adjust: Titrate oxygen to maintain target saturation.
-
Arterial Blood Gas (ABG): Check ABG after 30–60 minutes of controlled oxygen therapy to assess for hypercapnia and acidosis.
-
Bronchodilators
- Short-Acting Bronchodilators:
-
Short-Acting Beta-Agonists (SABA):
- Salbutamol: 2.5–5 mg via nebuliser, every 4–6 hours.
- Alternatively, 100–200 mcg via metered-dose inhaler (MDI) with a spacer, up to 10 puffs every 20 minutes for the first hour, then as needed.
-
Short-Acting Muscarinic Antagonists (SAMA):
- Ipratropium Bromide: 500 mcg via nebuliser, every 6–8 hours.
- Alternatively, 20–40 mcg via MDI with a spacer, up to 4 puffs every 6 hours.
-
Combination: Nebulised salbutamol 2.5–5 mg and ipratropium bromide 500 mcg together every 4–6 hours.
-
Corticosteroids
- Oral Corticosteroids:
- Prednisolone:
- Dose: 30 mg once daily for 5 days.
- Tapering: Usually not required for a 5-day course. If treatment exceeds 2 weeks, consider tapering the dose.
- Prednisolone:
Antibiotics
- Antibiotics:
- Consider antibiotics if the patient has:
- Increased dyspnoea
- Increased sputum volume
- Increased sputum purulence
- First-Line:
- Amoxicillin: 500 mg three times daily for 5 days.
- Penicillin Allergy or if Pseudomonas is a consideration:
- Doxycycline: 200 mg on the first day, then 100 mg once daily for 4 days.
- Clarithromycin: 500 mg twice daily for 5 days.
- Frequent Exacerbations or Severe COPD:
- Amoxicillin-Clavulanate: 625 mg three times daily for 5 days.
- Levofloxacin: 500 mg once daily for 5 days if Pseudomonas aeruginosa is a consideration.
- Consider antibiotics if the patient has:
Non-Invasive Ventilation (NIV)
- Non-Invasive Ventilation (NIV):
- Consider NIV for patients with persistent hypercapnic ventilatory failure (pH <7.35) despite optimal medical therapy.
- Settings:
- Inspiratory Positive Airway Pressure (IPAP): Start at 10–15 cm H2O, titrate up as tolerated.
- Expiratory Positive Airway Pressure (EPAP): Start at 4–5 cm H2O.
- Monitoring: Continuously monitor the patient’s response, including ABGs after 1–2 hours of NIV.
Other Interventions
-
Nebulised Magnesium Sulfate:
- Consider in patients who do not respond adequately to initial bronchodilator therapy.
- Dose: 2 g (8 mmol) in 5 mL of 0.9% sodium chloride, given via nebuliser.
-
Mucolytics:
- Not routinely recommended. Consider in patients with viscous sputum who have difficulty clearing secretions.
- Carbocisteine: 750 mg three times daily.
-
Fluid Management:
- Ensure adequate hydration but avoid fluid overload, particularly in patients with heart failure.
-
Venous Thromboembolism (VTE) Prophylaxis:
- Consider pharmacological VTE prophylaxis for patients who are hospitalised and have significantly reduced mobility.
- Low Molecular Weight Heparin (LMWH): e.g., enoxaparin 40 mg subcutaneously once daily.
Discharge Planning
-
Discharge Criteria:
- Stable oxygen saturation without supplemental oxygen.
- Able to walk around the ward.
- Eating and drinking normally.
- No significant comorbidities requiring further hospital treatment.
-
Follow-Up:
- Arrange a follow-up appointment within 4–6 weeks.
- Review inhaler technique and adherence.
- Consider pulmonary rehabilitation.
Patient Education
- Self-Management:
- Provide a written action plan.
- Educate the patient on recognising early signs of exacerbation.
- Ensure the patient knows when and how to start rescue medications, including oral corticosteroids if prescribed.
These guidelines provide a structured approach to managing acute COPD exacerbations, optimising patient outcomes through timely and appropriate interventions. Always individualise treatment based on patient-specific factors and response to therapy.
-
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.